Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Abdelmoez, AA; Thurner, GC; Wallnöfer, EA; Klammsteiner, N; Kremser, C; Talasz, H; Mrakovcic, M; Fröhlich, E; Jaschke, W; Debbage, P.
Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.
Histochem Cell Biol. 2010; 134(2): 171-196. Doi: 10.1007/s00418-010-0726-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-authors Med Uni Graz
Fröhlich Eleonore
Fröhlich Maria
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
We are developing a nanoparticulate histochemical reagent designed for histochemistry in living animals (molecular imaging), which should finally be useful in clinical imaging applications. The iterative development procedure employed involves conceptual design of the reagent, synthesis and testing of the reagent, then redesign based on data from the testing; each cycle of testing and development generates a new generation of nanoparticles, and this report describes the synthesis and testing of the third generation. The nanoparticles are based on human serum albumin and the imaging modality selected is magnetic resonance imaging (MRI). Testing the second particle generation with newly introduced techniques revealed the presence of impurities in the final product, therefore we replaced dialysis with diafiltration. We introduced further testing methods including thin layer chromatography, arsenazo III as chromogenic assay for gadolinium, and several versions of polyacrylamide gel electrophoresis, for physicochemical characterisation of the nanoparticles and intermediate synthesis compounds. The high grade of chemical purity achieved by combined application of these methodologies allowed standardised particle sizes to be achieved (low dispersities), and accurate measurement of critical physicochemical parameters influencing particle size and imaging properties. Regression plots confirmed the high purity and standardisation. The good degree of quantitative physicochemical characterisation aided our understanding of the nanoparticles and allowed a conceptual model of them to be prepared. Toxicological screening demonstrated the extremely low toxicity of the particles. The high magnetic resonance relaxivities and enhanced mechanical stability of the particles make them an excellent platform for the further development of MRI molecular imaging.
Find related publications in this database (using NLM MeSH Indexing)
Contrast Media - chemistry
Drug Design -
Drug Stability -
Humans -
Magnetic Resonance Imaging - methods
Materials Testing -
Nanoparticles - chemistry
Serum Albumin - chemistry

Find related publications in this database (Keywords)
Albumin nanoparticles
MRI
Gadolinium
Targeting
PEGylation
Molecular imaging
© Med Uni GrazImprint